Abstract
Wilson’s disease (WD) with extensive cortico-subcortical lesions represents a rare neuropathological subgroup, the pathogenesis of which is not clearly determined. We report two new cases with identical lesions. In the families of each of the patient, there were mutations in the ATPase7B gene, especially in the family of proband 1, and in the first cousin of proband 2. These cases included massive destruction of the white matter in superior gyri, mostly frontal, extending to the deep cortex with neuronal loss and capillary proliferation. Astrocytes were of Alzheimer type 1 and 2; and type 1 were labeled by anti-metallothionein. Opalski cells were abundant and their macrophagic lineage was confirmed by immunostaining. Among the possible mechanisms proposed, the role of vascular factors and penicillamine treatment could be excluded. Cerebral copper content in white matter and putamen of case 1 was at the same level as in common WD but accumulation of unbound copper in the white matter was a distinctive feature, which suggested a pathological neurotoxic effect.
Similar content being viewed by others
References
Aisen AM, Martel W, Gabrielsen TO, Glazer GM, Brewer G, Young AB, Hill G (1985) Wilson disease of the brain: MR imaging. Radiology 157:137–141
Alajouanine T, Bertrand I, Boudin G, Pepin B (1955) Etude anatomo-clinique, biologique et chimique d’un cas de pseudo-sclérose de Westphal-Strumpell. Rev Neurol (Paris) 93:701–729
Anton G 1908 cited by Finlayson and Superville
Anzil AP, Herrlinger H, Blinzinger K, Heldrich A (1974) Ultrastructure of brain and nerve biopsy tissue in Wilson disease. Arch Neurol 31:94–100
Brewer GJ, Terry CA, Aisen AM, Hill GM (1987) Worsening of neurologic syndrome in patients with Wilson’s disease with initial penicillamine therapy. Arch Neurol 44:490–493
Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5:327–337
Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284–294
Butterworth RF (1992) Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 37:321–327
Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17:221–227
Cavanagh JB, Harding BN (1994) Pathogenic factors underlying the lesions in Leigh’s disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 117:1357–1376
Chu NS (1989) Clinical, CT and evoked potential manifestations in Wilson’s disease with cerebral white matter involvement. Clin Neurol Neurosurg 91:45–51
Cumings JN (1949) The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 71:410–415
Duc HH, Hefter H, Stremmel W, Castaneda-Guillot C, Hernandez Hernandez A, Cox DW, Auburger G (1998) His1069Gln and six novel Wilson disease mutations: analysis of relevance for early diagnosis and phenotype. Eur J Hum Genet 6:616–623
Ferenci P (1999) Wilson’s disease. Ital J Gastroenterol Hepatol 31:416–425
Finlayson MH, Superville B (1981) Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 104:79–95
Gitlin JD (2003) Wilson disease. Gastroenterology 125:1868–1877
Gu M, Cooper JM, Butler P, Walker AP, Mistry PK, Dooley JS, Schapira AH (2000) Oxidative-phosphorylation defects in liver of patients with Wilson’s disease. Lancet 356:469–474
Hall H (1921) La dégénérescence hépato-lenticulaire: maladie de Wilson—pseudo-sclérose. Masson, Paris
Hermann W, Caca K, Eggers B, Villmann T, Clark D, Berr F, Wagner A (2002) Genotype correlation with fine motor symptoms in patients with Wilson’s disease. Eur Neurol 48:97–101
Homen EA 1892 cited by Finlayson and Superville
Horoupian DS, Sternlieb I, Scheinberg IH (1988) Neuropathological findings in penicillamine-treated patients with Wilson’s disease. Clin Neuropathol 7:62–67
Huang CC, Chu NS (1992) Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson’s disease: report of a case. J Formos Med Assoc 91:627–629
Ishino H, Mii T, Hayashi Y, Saito A, Otsuki S (1972) A case of Wilson’s disease with enormous cavity formation of cerebral white matter. Neurology 22:905–909
Konowalow N (1941) Histopathologie der hepato-lentikulären Degeneration. Z Ges Neurol Psychiatr 171:200–228
Lawler GA, Pennock JM, Steiner RE, Jenkins WJ, Sherlock S, Young IR (1983) Nuclear magnetic resonance (NMR) imaging in Wilson disease. J Comput Assist Tomogr 7:1–8
Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216–221
Loudianos G, Dessi V, Lovicu M, Angius A, Nurchi A, Sturniolo GC, Marcellini M, Zancan L, Bragetti P, Akar N, Yagci R, Vegnente A, Cao A, Pirastu M (1998) Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 12:89–94
Maier-Dobersberger T, Ferenci P, Polli C, Balac P, Dienes HP, Kaserer K, Datz C, Vogel W, Gangl A (1997) Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 127:21–26
Nayrac P, Graux P, Van Bogaert L, Rabache R (1957) Etude biochimique et histologique sur une fratrie wilsonienne d’une stricte homotypie anatomoclinique. Rev Neurol (Paris) 96:196–215
Richter R (1948) The pallial component in hepato-lenticular degeneration. J Neuropathol Exp Neurol 7:1–18
Schulman S (1968) Wilson’s disease. In: Minckler J (ed) Pathology of the nervous system, vol 1. McGraw-Hill, New York, pp 1139–1162
Schulman S, Barbeau A (1963) Wilson’s disease: a case with almost total loss of white matter. J Neuropathol Exp Neurol 22:105–119
Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, Pavone L, Evgrafov O, Ivanova-Smolenskaya IA, Anneren G, Westermark K, Urrutia FH, Penchaszadeh GK, Sternlieb I, Scheinberg IH, Gilliam TC, Petrukhin K (1997) Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 61:317–328
Sheline CT, Choi EH, Kim-Han JS, Dugan LL, Choi DW (2002) Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann Neurol 52:195–204
Shimoji A, Miyakawa T, Watanabe K, Yamashita K, Katsuragi S, Kabashima K (1987) Wilson’s disease with extensive degeneration of cerebral white matter and cortex. Jpn J Psychiatry Neurol 41:709–717
Sparaco M, Bonilla E, DiMauro S, Powers JM (1993) Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52:1–10
Spielmeyer W (1920) Die histopathologische Zusammenhörigkeit der Wilsonschen Krankheit. Z Ges Neurol Psychiatr 57:312–351
Starosta-Rubinstein S, Young AB, Kluin K, Hill G, Aisen AM, Gabrielsen T, Brewer GJ (1987) Clinical assessment of 31 patients with Wilson’s disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 44:365–370
Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM (1993) The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344–350
Thomas GR, Roberts EA, Walshe JM, Cox DW (1995) Haplotypes and mutations in Wilson disease. Am J Hum Genet 56:1315–1319
Walker JM, Tsivkovskii R, Lutsenko S (2002) Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson’s disease protein and regulates its catalytic activity. J Biol Chem 277:27953–27959
Wang XF, Cynader MS (2001) Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J Neurosci 21:3322–3331
White AR, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI, Beyreuther K, Masters CL, Cappai R (1999) The Alzheimer’s disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J Neurosci 19:9170–9179
Wilson S (1912) Progressive lenticular degeneration:a familial nervous disease associated with cirrhosis of the liver. Brain 34:295–507
Yoshii F, Takahashi W, Shinohara Y (1996) A Wilson’s disease patient with prominent cerebral white matter lesions: five-year follow-up by MRI. Eur Neurol 36:392–393
Acknowledgements
We wish to thank Prof. F. Gray and Dr. A. Lombes for special techniques, P. Castagnet and C. Poiron for excellent technical assistance, M.-L. Peyronnet for typing the manuscript and D. Robinson and M. O’Gara for linguistic help.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mikol, J., Vital, C., Wassef, M. et al. Extensive cortico-subcortical lesions in Wilson’s disease: clinico-pathological study of two cases. Acta Neuropathol 110, 451–458 (2005). https://doi.org/10.1007/s00401-005-1061-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-005-1061-1